<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-03T14:37:29Z</responseDate><request verb="GetRecord" identifier="oai:riuma.uma.es:10630/18493" metadataPrefix="rdf">https://riuma.uma.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:riuma.uma.es:10630/18493</identifier><datestamp>2026-02-03T11:49:02Z</datestamp><setSpec>com_10630_2254</setSpec><setSpec>col_10630_37959</setSpec></header><metadata><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:ds="http://dspace.org/ds/elements/1.1/" xmlns:ow="http://www.ontoweb.org/ontology/1#" xmlns:rdf="http://www.openarchives.org/OAI/2.0/rdf/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/rdf/ http://www.openarchives.org/OAI/2.0/rdf.xsd">
   <ow:Publication rdf:about="oai:riuma.uma.es:10630/18493">
      <dc:title>The graphene oxide species induce a different biological response in SN4741 Parkinson cell line</dc:title>
      <dc:creator>Rodríguez-Losada, Noela</dc:creator>
      <dc:creator>Wendelbo, Rune</dc:creator>
      <dc:creator>Aguirre-Gómez, José Ángel</dc:creator>
      <dc:creator>Ocaña Farfán, María del Carmen</dc:creator>
      <dc:creator>Arráez-Sánchez, Miguel Ángel</dc:creator>
      <dc:creator>Díaz-Casares, Amelia</dc:creator>
      <dc:creator>Medina-Torres, Miguel Ángel</dc:creator>
      <dc:creator>Martínez-Moreno, José Manuel</dc:creator>
      <dc:creator>Arenas, Ernest</dc:creator>
      <dc:creator>Narváez-Bueno, José Ángel</dc:creator>
      <dc:subject>Parkinson, Enfermedad de - Tratamiento</dc:subject>
      <dc:subject>Óxido de grafeno - Aplicaciones</dc:subject>
      <dc:subject>Óxido de grafeno - Propiedades</dc:subject>
      <dc:description>Introduction: Graphene Oxide (GO)has recently emerged as a reliable material to create scaffolds for the neural tissue because of its biocompatibility, electroconductive and physicochemical properties. Graphene is a 2-dimensional material consisting of rings of carbon atoms with an excellent electrical conductivity originating in the sp2 hybridized carbons network. Nevertheless, there is not a consensus which kind of graphene oxide is most useful of benefit.</dc:description>
      <dc:date>2019-09-30T10:30:23Z</dc:date>
      <dc:date>2019-09-30T10:30:23Z</dc:date>
      <dc:date>2019</dc:date>
      <dc:date>2019-09-30</dc:date>
      <dc:type>conference output</dc:type>
      <dc:identifier>https://hdl.handle.net/10630/18493</dc:identifier>
      <dc:language>eng</dc:language>
      <dc:relation>CONGRESO NACIONAL DE NEUROCIENCIA</dc:relation>
      <dc:relation>SANTIAGO DE COMPOSTELA</dc:relation>
      <dc:relation>4-9-2019</dc:relation>
      <dc:rights>open access</dc:rights>
   </ow:Publication>
</rdf:RDF>
</metadata></record></GetRecord></OAI-PMH>